2026

Novel deiodinase 2-selective inhibitors - possible reference substances for regulatory in vitro tests for endocrine disruptors and drugs targeting T3-dependent processes.
Frädrich, Caroline, Wiese, Niklas, Zhang, Yiming, Sane, Rajas, Fischbach, Anja, Wirth, Eva K., Neuenschwander, Martin ORCID: https://orcid.org/0000-0002-3114-7975, von Kries, Jens Peter ORCID: https://orcid.org/0000-0003-4716-4988, Seyffarth, Carola, Kleissle, Sabrina, Renko, Kostja and Köhrle, Josef
Thyroid 36 (4): 451-462. 1 April 2026

2025

Identification and characterization of highly potent and isoenzyme-selective inhibitors of deiodinase type I via a nonradioactive high-throughput screening method.
Sane, R. ORCID: https://orcid.org/0000-0002-8245-8853, Seyffarth, C., Kleissle, S., Neuenschwander, M. ORCID: https://orcid.org/0000-0002-3114-7975, von Kries, J.P. ORCID: https://orcid.org/0000-0003-4716-4988, Frädrich, C., Renko, K., Wirth, E.K. ORCID: https://orcid.org/0000-0002-0491-9941 and Köhrle, J. ORCID: https://orcid.org/0000-0002-9187-9078
Thyroid 35 (5): 576-589. 15 May 2025

2024

Partial resistance to thyroid hormone-induced tachycardia and cardiac hypertrophy in mice lacking thyroid hormone receptor β.
Dore, R. ORCID: https://orcid.org/0000-0001-5988-9885, Sentis, S.C., Johann, K. ORCID: https://orcid.org/0000-0002-5089-7237, Lopez-Alcantara, N., Resch, J., Chandrasekar, A., Müller-Fielitz, H. ORCID: https://orcid.org/0000-0003-2815-4426, Moeller, L.C., Fuehrer, D., Schwaninger, M., Obermayer, B. ORCID: https://orcid.org/0000-0002-9116-630X, Opitz, R. ORCID: https://orcid.org/0000-0003-3143-0997 and Mittag, J. ORCID: https://orcid.org/0000-0001-7778-5158
Thyroid 34 (6): 796-805. June 2024

2021

Thyrotropin receptor-specific lymphocytes in adenovirus-TSHR-immunized native and human leukocyte antigen-DR3-transgenic mice and in Graves' disease patient blood.
Degen, H., Gavvovidis, I. ORCID: https://orcid.org/0000-0001-5644-9788, Blankenstein, T. ORCID: https://orcid.org/0000-0002-3357-4321, Uhland, K. and Ungerer, M.
Thyroid 31 (6): 950-963. June 2021

2019

A new highly thyrotropin receptor-selective small molecule antagonist with potential for the treatment of Graves' orbitopathy.
Marcinkowski, P., Hoyer, I., Specker, E. ORCID: https://orcid.org/0000-0002-9471-9520, Furkert, J., Rutz, C., Neuenschwander, M. ORCID: https://orcid.org/0000-0002-3114-7975, Sobottka, S., Sun, H., Nazare, M. ORCID: https://orcid.org/0000-0002-1602-2330, Berchner-Pfannschmidt, U., von Kries, J.P. ORCID: https://orcid.org/0000-0003-4716-4988, Eckstein, A., Schülein, R. and Krause, G.
Thyroid 29 (1): 111-123. 23 January 2019

2015

RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells.
Medapati, M.R., Dahlmann, M. ORCID: https://orcid.org/0000-0002-0036-5283, Ghavami, S., Pathak, K.A., Lucman, L., Klonisch, T., Hoang-Vu, C., Stein, U. ORCID: https://orcid.org/0000-0001-7006-282X and Hombach-Klonisch, S.
Thyroid 25 (5): 514-527. 4 May 2015

2010

Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
Kim, T.D., Schwarz, M., Nogai, H., Grille, P., Westermann, J., Ploeckinger, U., Braun, D., Schweizer, U., Arnold, R., Doerken, B. ORCID: https://orcid.org/0000-0001-7991-3643 and le Coutre, P.
Thyroid 20 (11): 1209-1214. 9 November 2010